KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Share-based Compensation (2016 - 2026)

Palvella Therapeutics has reported Share-based Compensation over the past 8 years, most recently at $949000.0 for Q4 2022.

  • Quarterly Share-based Compensation fell 28.11% to $949000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2022, down 15.59% year-over-year, with the annual reading at $6.4 million for FY2025, 671.2% up from the prior year.
  • Share-based Compensation was $949000.0 for Q4 2022 at Palvella Therapeutics, down from $974000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $1.5 million in Q3 2019 and troughed at $949000.0 in Q4 2022.
  • The 5-year median for Share-based Compensation is $1.3 million (2019), against an average of $1.3 million.
  • Year-over-year, Share-based Compensation soared 141.3% in 2018 and then dropped 28.91% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $1.3 million in 2018, then dropped by 12.83% to $1.1 million in 2019, then grew by 5.39% to $1.2 million in 2020, then rose by 12.44% to $1.3 million in 2021, then dropped by 28.11% to $949000.0 in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Share-based Compensation are $949000.0 (Q4 2022), $974000.0 (Q3 2022), and $1.3 million (Q2 2022).